These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 3798343

  • 1. [Prognostic significance of the HBeAg-anti-HBe system in acute hepatitis B].
    Ketiladze ES, Vorozhbieva TE, Matveev VA, Bugaeva NP.
    Ter Arkh; 1986; 58(10):23-6. PubMed ID: 3798343
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical and pathophysiological aspects of chronic active hepatitis.
    Iwamura K.
    Tokai J Exp Clin Med; 1986; 11 Suppl():147-57. PubMed ID: 3452239
    [Abstract] [Full Text] [Related]

  • 4. [Clinical course and outcome of acute hepatitis B in relation to the markers of the E system].
    Iushchuk ND, Shestakova IV, Klimova EA, Sergeeva NA, Malyshev NA, Braginskiĭ DM, Favorov MO.
    Ross Med Zh; 1992; (4):42-4. PubMed ID: 1521021
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Seroconversion of HBeAg into anti-HBe in chronic hepatitis type B].
    Stránský J, Vodák M, Zichová M, Votruba T, Choluj B.
    Cas Lek Cesk; 1986 Oct 31; 125(44):1353-6. PubMed ID: 3508397
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B, Nazarewicz-de Mezer T, Krawczyński K.
    Przegl Epidemiol; 1984 Oct 31; 38(3):249-56. PubMed ID: 6528039
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [A clinicopathological study of seroconversion from HBeAg to anti-HBe in patients with chronic hepatitis B].
    Liu JH, Yan JC, Wang HP.
    Zhonghua Nei Ke Za Zhi; 1988 Oct 31; 27(10):621-3, 653. PubMed ID: 3229186
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The behavior of the HBeAg-anti-HBe system in chronic hepatitis].
    Musca A, Cordova C, Barnaba V, Bonavita MS, Zaccari C, Levrero M.
    Minerva Dietol Gastroenterol; 1983 Oct 31; 29(1):19-26. PubMed ID: 6843853
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Viral markers of hepatitis A and B: main characteristics and clinical significance].
    Lyra LG.
    Arq Gastroenterol; 1983 Oct 31; 20(3):117-22. PubMed ID: 6329145
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Co-existence of HBeAg and anti-HBe in a subject with prolonged hepatitis B].
    Cirelli A, Catania S.
    Clin Ter; 1981 Jul 31; 98(2):215-7. PubMed ID: 7261568
    [No Abstract] [Full Text] [Related]

  • 19. The HBe antigen-antibody system and its relationship to epidemiological, histological and biochemical findings in patients with HBV+ HDV chronic liver diseases.
    Jelić D, Jelić O.
    Acta Med Croatica; 1994 Jul 31; 48(2):77-83. PubMed ID: 7519502
    [Abstract] [Full Text] [Related]

  • 20. Low frequency of precore hepatitis B virus mutants in anti-hepatitis B e-positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B.
    Loriot MA, Marcellin P, Talbodec N, Guigonis V, Gigou M, Boyer N, Bezeaud A, Erlinger S, Benhamou JP.
    Hepatology; 1995 Mar 31; 21(3):627-31. PubMed ID: 7875659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.